Document and Entity Information [Abstract]
Statement [Table]
Statement [Line Items]
Document Type
Document Quarterly Report
Document Period End Date
Document Transition Report
Securities Act File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Shell Company
Entity Common Stock, Shares Outstanding
Entity Central Index Key
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Amendment Flag
CONDENSED CONSOLIDATED BALANCE SHEETS
Assets [Abstract]
ASSETS
Assets, Current [Abstract]
Current assets:
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Restricted Cash, Current
Restricted cash
Short-Term Investments
Short-term investments
Restricted Investments, Current
Restricted short-term investments
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts receivable, net
Inventory, Net
Inventories
Total inventories
Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds and deposits of overpayments or recoveries based on agreed-upon resolutions of disputes.
Income Tax Refund And deposits
Income tax refunds and deposits
Prepaid Expense and Other Assets, Current
Prepaid expenses and other assets
Assets, Current
Total current assets
Property, Plant and Equipment, Net
Total property, plant, and equipment, net
Property, plant, and equipment, net
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Finance lease right-of-use assets
Operating lease right-of-use assets
Right-of-use assets
Intangible Assets, Net (Including Goodwill)
Balance, Net Book Value
Goodwill and intangible assets, net
Other Assets, Noncurrent
Other assets
Deferred Income Tax Assets, Net
Deferred tax assets
Assets
Total assets
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities, Current [Abstract]
Current liabilities:
Accounts Payable and Accrued Liabilities, Current
Accounts payable and accrued liabilities
Total accounts payable and accrued liabilities
Accrued Income Taxes, Current
Income taxes payable
Long-Term Debt and Lease Obligation, Current
Less current portion of long-term debt and finance leases
Current portion of long-term debt
Operating Lease, Liability, Current
Current portion of operating lease liabilities
Liabilities, Current
Total current liabilities
Accrued Income Taxes, Noncurrent
Long-term reserve for income tax liabilities
Long-Term Debt and Lease Obligation
Long-term debt, net of current portion and unamortized debt issuance costs
Operating Lease, Liability, Noncurrent
Long-term operating lease liabilities, net of current portion
Other Liabilities, Noncurrent
Other long-term liabilities
Liabilities
Total liabilities
Commitments and Contingency
Commitments and contingencies (see Note 17)
Equity, Attributable to Parent [Abstract]
Stockholders' equity:
Preferred Stock, Value, Issued
Preferred stock: par value $0.0001; 20,000,000 shares authorized; no shares issued and outstanding
Common Stock, Value, Issued
Common stock: par value $0.0001; 300,000,000 shares authorized; 62,134,449 and 44,636,846 shares issued and outstanding, respectively, as of March 31, 2026 and 61,779,883 and 45,645,497 shares issued and outstanding, respectively, as of December 31, 2025
Additional Paid in Capital
Additional paid-in capital
Retained Earnings (Accumulated Deficit)
Retained earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive loss
Treasury Stock, Value
Treasury stock
Equity, Including Portion Attributable to Noncontrolling Interest
Balance
Balance
Total stockholders' equity
Liabilities and Equity
Total liabilities and stockholders' equity
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value (in dollars per share)
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Preferred Stock, Shares Issued
Preferred stock, shares issued
Preferred Stock, Shares Outstanding
Common Stock, Par or Stated Value Per Share
Common stock, par value (in dollars per share)
Common Stock, Shares Authorized
Common stock; shares authorized
Common Stock, Shares, Issued
Common stock; shares issued
Common Stock, Shares, Outstanding
Balance
Balance
Common stock; shares outstanding
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues [Abstract]
Net Revenues:
Revenues
Revenue
Net revenues
Cost of Revenue
Cost of revenues
Gross Profit
Gross profit
Operating Expenses [Abstract]
Operating expenses:
Selling and Marketing Expense
Selling, distribution, and marketing
General and Administrative Expense
General and administrative
Research and Development Expense
Research and development
Operating Expenses
Total operating expenses
Operating Income (Loss)
Income from operations
Nonoperating Income (Expense) [Abstract]
Non-operating income (expenses):
Investment Income, Interest
Interest income
Interest income
Interest Expense, Nonoperating
Interest expense
Interest expense
Other Nonoperating Income (Expense)
Other income (expenses), net
Nonoperating Income (Expense)
Total non-operating income (expenses), net
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Total income before income taxes
Income before income taxes
Income Tax Expense (Benefit)
Income tax provision
Net income
Net income
Net Income per Share
Net income per share:
Earnings Per Share, Basic
Net income (loss) per share - basic
Basic
Earnings Per Share, Diluted
Net income (loss) per share - diluted
Diluted
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted-average shares used to compute net income per share:
Weighted Average Number of Shares Outstanding, Basic
Weighted-average shares outstanding-basic
Basic (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average shares outstanding - diluted
Diluted (in Shares)
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income (loss), net of income taxes
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Foreign currency translation adjustment
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax
Change in pension obligations
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Total other comprehensive income (loss)
Other comprehensive income (loss)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Total comprehensive income
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
Equity Components [Axis]
Equity Component [Domain]
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in Stockholders' Equity
Equity, Attributable to Parent
Balance
Balance
Treasury Stock, Common, Shares
Balance
Balance
Treasury Stock, Value, Acquired, Cost Method
Purchase of treasury stock
Treasury Stock, Shares, Acquired
Purchase of treasury stock (in Shares)
Stock Issued During Period, Value, Treasury Stock Reissued
Issuance of treasury stock in connection with the Company's equity plans
Stock Issued During Period, Shares, Treasury Stock Reissued
Issuance of treasury stock in connection with the Company's equity plans (in Shares)
Value of shares issued under equity plans.
Stock Issued During Period Value Equity Plans
Issuance of common stock in connection with the Company's equity plans
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture
Issuance of common stock in connection with the Company's equity plans (in Shares)
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Share-based compensation expense
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Cash Flows From Operating Activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net income
Net income
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Reconciliation to net cash provided by operating activities:
Gain (Loss) on Disposition of Assets
Loss on disposal of assets
Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments
(Gain) loss on interest rate swaps and foreign currency transactions, net
Depreciation
Depreciation of property, plant, and equipment
Amortization of intangible assets
Operating Lease, Right-of-Use Asset, Periodic Reduction
Operating lease right-of-use asset amortization
Amortization of Debt Issuance Costs and Discounts
Amortization of discounts, premiums, and debt issuance costs
Share-Based Payment Arrangement, Noncash Expense
Share-based compensation expense
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable
Accounts receivable, net
Increase (Decrease) in Inventories
Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid expenses and other assets
Increase Decrease In Income Tax Refund, Deposits, and Payable
Increase Decrease In Income Tax Refund, Deposits, and Payable
Income tax refunds, deposits, and payable, net
Amount of lessee's right to use underlying asset under operating lease, net of present value of lessee's discounted obligation for lease payments from operating lease.
Operating Lease Right Of Use Assets And Liabilities Net
Operating lease liabilities
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities
Net Cash Provided by (Used in) Operating Activities
Net cash provided by operating activities
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
Cash Flows From Investing Activities:
Payments to Acquire Property, Plant, and Equipment
Purchases and construction of property, plant, and equipment
Payments to Acquire Marketable Securities
Purchase of investments
Proceeds from Sale and Maturity of Marketable Securities
Maturity of investments
Cash outflow related to payments and other deposits not otherwise defined in the taxonomy.
Payments For Deposits And Other Assets
Deposits and other assets
Net Cash Provided by (Used in) Investing Activities
Net cash (used in) provided by investing activities
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
Cash Flows From Financing Activities:
The total cash inflow or outflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises, net of withholding tax payments upon issuance to employees. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options, Net Of Withholding Tax Payments
Proceeds from equity plans, net of withholding tax payments
Payments for Repurchase of Common Stock
Purchase of treasury stock
Payments for repurchase of common stock
Payments of Debt Issuance Costs
Debt issuance costs
Proceeds from Lines of Credit
Proceeds from borrowing under lines of credit
Repayments of Long-Term Debt
Principal payments on long-term debt
Net Cash Provided by (Used in) Financing Activities
Net cash used in financing activities
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Effect of exchange rate changes on cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net increase in cash, cash equivalents, and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Cash, cash equivalents, and restricted cash at end of period
Cash, cash equivalents, and restricted cash at beginning of period
Noncash Investing and Financing Items [Abstract]
Noncash Investing and Financing Activities:
Capital Expenditures Incurred but Not yet Paid
Capital expenditures included in accounts payable
Amount of lessee's right to use underlying asset under operating lease in noncash investing or financing activities.
Noncash Operating Lease Right Of Use Asset
Operating lease right-of-use assets in exchange for operating lease liabilities
Supplemental Cash Flow Information [Abstract]
Supplemental Disclosures of Cash Flow Information:
Interest Paid, Excluding Capitalized Interest, Operating Activities
Interest paid, net of capitalized interest
Income Taxes Paid, Net
Income taxes paid (refunded)
General
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
General
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Revenue Recognition
The entire disclosure for revenue recognition.
Revenue Recognition Disclosure [Text Block]
Revenue Recognition
Earnings Per Share [Text Block]
Net Income per Share
Segment Reporting
Segment Reporting Disclosure [Text Block]
Segment Reporting
Customer and Supplier Concentration
Concentration Risk Disclosure [Text Block]
Customer and Supplier Concentration
Fair Value Measurements
Fair Value Disclosures [Text Block]
Fair Value Measurements
Investments
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Investments
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block]
Goodwill and Intangible Assets
Inventories
Inventory Disclosure [Text Block]
Inventories
Property, Plant, and Equipment.
Property, Plant and Equipment Disclosure [Text Block]
Property, Plant, and Equipment
Accounts Payable and Accrued Liabilities.
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Accounts Payable and Accrued Liabilities
Debt
Debt Disclosure [Text Block]
Debt
Income Taxes
Income Tax Disclosure [Text Block]
Income Taxes
Stockholders' Equity
Equity [Text Block]
Stockholders' Equity
Employee Benefits
Retirement Benefits [Text Block]
Employee Benefits
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Related-Party Transactions
Related Party Transactions Disclosure [Text Block]
Related-Party Transactions
Litigation
Legal Matters and Contingencies [Text Block]
Litigation
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency
Comprehensive Income, Policy [Policy Text Block]
Comprehensive Income
Advertising Cost [Policy Text Block]
Advertising Expense
Research and Development Expense, Policy [Policy Text Block]
Research and Development Costs
Fair Value of Financial Instruments, Policy [Policy Text Block]
Financial Instruments
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
Investment, Policy [Policy Text Block]
Investments
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Restricted Cash
Disclosure of accounting policy for restricted short-term investments.
Restricted Short-term Investments [Policy Text Block]
Restricted Short-Term Investments
Income Tax, Policy [Policy Text Block]
Deferred Income Taxes
Debt, Policy [Policy Text Block]
Debt Issuance Costs
Disclosure of accounting policy related to convertible debt.
Convertible Debt Policy Text Block
Convertible Debt
Internal Use Software, Policy [Policy Text Block]
Capitalized Software Implementation Costs
Commitments and Contingencies, Policy [Policy Text Block]
Litigation, Commitments and Contingencies
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
The provision for chargebacks is a significant estimate used in the recognition of revenue. As part of its sales terms with wholesale customers, the Company agrees to reimburse wholesalers for differences between the gross sales prices, at which the Company sells its products to wholesalers and the actual prices of such products at the time wholesalers resell them under the Company's various contractual arrangements with third parties such as hospitals and group purchasing organizations. The Company estimates chargebacks at the time of sale to wholesalers based on wholesaler inventory stocking levels, historic chargeback rates, and current contract pricing.
Schedule of Chargeback Liability [Table Text Block]
Schedule of chargeback and rebates provision analysis
Tabular disclosure of the amounts that are recognized in the balance sheet for chargebacks and rebates.
Schedule Of Provision For Chargebacks And Rebates Amounts Recognized In Balance Sheet Table Text Block
Schedule of provision of chargebacks and rebates as reflected in the balance sheets
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of basic and diluted net income (loss) per share calculation
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of financial information by reporting segment
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]
Schedule of net revenues in the finished pharmaceutical products segment
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Schedule of net revenues and carrying values of long-lived assets by geographic region
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
Schedule of accounts receivable and net revenues by major customer
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Schedule of financial assets and liabilities measured on a recurring basis
Debt Securities, Held-to-Maturity [Table Text Block]
Schedule of securities classified as held-to-maturity
Tabular disclosure of amortizable finite-lived intangible assets, in total and by major class, including the gross carrying amount and accumulated amortization, and indefinite-lived intangible assets not subject to amortization, excluding goodwill, in total and by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.
Schedule Of Finite Lived And Indefinite Lived Intangible Assets By Major Class Table Text Block
Schedule of weighted-average life, original cost, accumulated amortization and net book value by major class
Schedule of Goodwill [Table Text Block]
Schedule of changes in carrying amounts of goodwill
Schedule of Inventory, Current [Table Text Block]
Schedule of inventories
Property, Plant and Equipment [Table Text Block]
Schedule of property, plant, and equipment
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of accounts payable and accrued liabilities
Schedule of Debt [Table Text Block]
Schedule of debt
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of reconciliation of the statutory federal income tax rate
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of key assumptions to determine fair value of options
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Schedule of the summary of option activity under all plans
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]
Schedule of information relating to options grants
Schedule of Nonvested Share Activity [Table Text Block]
Schedule of the summary of nonvested options status
Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]
Schedule of information relating to RSU grants and deliveries
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Schedule of recorded share-based compensation expense under all plans
Lease, Cost [Table Text Block]
Schedule of lease costs
Tabular disclosure of other information pertaining to leases.
Schedule Of Leases Other Information Table Text Block
Schedule of other information pertaining to leases
Tabular disclosure of undiscounted cash flows of lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to lease liability recognized in statement of financial position.
Lease Liability Maturity [Table Text Block]
Schedule of future minimum payments
Nature of Operation, Product Information, Concentration of Risk [Table]
Subsegments [Axis]
Subsegments [Domain]
Represents Primatene MIST.
Primatene MIST
Product Information [Line Items]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax
Gains and (losses) of intercompany foreign currency transactions
Advertising Expense
Advertising expense
Certificates of Deposit, at Carrying Value
Capitalized Computer Software, Gross
Capitalized computer software
Capitalized Computer Software, Amortization
Capitalized computer software amortization
Disaggregation of Revenue [Table]
Statistical Measurement [Axis]
Statistical Measurement [Domain]
Minimum
Maximum
Product and Service [Axis]
Product and Service [Domain]
Services for research and development.
Research and development services
Legal Entity [Axis]
All Entities
ANP [Member]
ANP
Disaggregation of Revenue [Line Items]
Payment terms in contract with customer, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration.
Revenue Performance Obligation Payment Terms
Payment terms
Represents the amount the Company agrees to reimburse wholesalers for differences between the gross sales prices, at which the Company sells its products to wholesalers and the actual prices of such products at the time wholesalers resell them under the Company's various contractual arrangements with third parties such as hospitals and group purchasing organizations.
Revenue Recognition Wholesaler Chargebacks
Ending balance
Beginning balance
Total
Represents the wholesaler chargeback provision related to sales made in the current period.
Provision for chargebacks and rebates
Represents wholesaler chargeback credits issued to third parties during the period.
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
Credits and payments issued to third parties
Statement of Financial Position Location, Balance [Axis]
Statement of Financial Position Location, Balance [Domain]
Accounts Receivable
Accounts Payable and Accrued Liabilities
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive Securities Excluded from Computation of Earnings Per Share, Shares
Represents the weighted-average exercise price of the excluded securities, per share.
Antidilutive Securities Excluded from Computation of Earnings Per Share, Exercise Price of Excluded Securities
Net Income (Loss) Available to Common Stockholders, Basic [Abstract]
Basic and dilutive numerator:
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Weighted-average shares outstanding - basic
Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]
Net effect of dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares
Incremental shares from equity awards
Schedule of Segment Reporting Information, by Segment [Table]
Segments [Axis]
Segments [Domain]
Represents pharmaceutical products segment.
Pharmaceutical products segment
Segment Reporting Information [Line Items]
Number of Reportable Segments
Labor and Related Expense
Payroll expense
Amount of expense for materials and supplies.
Materials And Supplies Expense
Materials and supplies
Amount of expense for clinical trials.
Clinical Trials Expense
Clinical trials expense
Depreciation, Depletion and Amortization
Depreciation and amortization expense
Share-Based Payment Arrangement, Expense
Stock-based compensation expense
Amount of expense for consulting and outside services.
Consulting And Outside Services Expense
Consulting and outside services expense
Marketing and Advertising Expense
Advertising and promotional expense
Segment Reporting, Other Segment Item, Amount
Other segment items
Segment Reporting, Other Segment Item, Composition, Description
Represents the finished pharmaceutical products segments of the business.
Finished Pharmaceutical Products Segment
Represents Glucagon.
Glucagon
Represents BAQSIMI.
BAQSIMI
Represents Epinephrine.
Epinephrine
Represents Lidocaine.
Lidocaine
Other Products [Member]
Other Products
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Schedule of Revenues from External Customers and Long-Lived Assets [Table]
Geographical [Axis]
Geographical [Domain]
UNITED STATES
China
France
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets
Schedule of Revenue by Major Customers, by Reporting Segments [Table]
Customer [Axis]
Customer [Domain]
The major customer Cencora Inc.
Cencora
The major customer McKesson.
McKesson
The major customer Cardinal Health.
Cardinal Health
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Domain]
Revenue Benchmark
Concentration Risk Type [Axis]
Concentration Risk Type [Domain]
Customer Concentration Risk
Revenue, Major Customer [Line Items]
Number of major customers.
Number Of Major Customers
Number of major customers
Concentration Risk, Percentage
Fair Value, Recurring and Nonrecurring [Table]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value, Inputs, Level 1
Fair Value, Inputs, Level 2
Measurement Frequency [Axis]
Measurement Frequency [Domain]
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure
Cash equivalents
Restricted Cash and Investments
Restricted cash
Investments, Fair Value Disclosure
Short-term investments
Restricted Investments, at Fair Value
Restricted short-term investments
Assets, Fair Value Disclosure
Total assets measured at fair value
Derivative Liability, Subject to Master Netting Arrangement, before Offset
Interest rate swaps related to variable rate loans
Interest rate swaps related to variable rate loans
Debt Securities, Held-to-Maturity [Table]
Financial Instrument [Axis]
Financial Instruments [Domain]
This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).
Corporate and agency bonds (due within 1 year)
Municipal Bonds
Schedule of Held-to-Maturity Securities [Line Items]
Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss
Amortized Cost
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain
Gross Unrealized Gains
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss
Gross Unrealized Losses
Debt Securities, Held-to-Maturity, Fair Value
Fair Value
Disclosure of finite-lived and indefinite-lived intangible assets, excluding goodwill, in total and by major class.
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]
Asset Acquisition [Axis]
Asset Acquisition [Domain]
Represents information pertaining to BAQSIMI acquisitions.
BAQSIMI product rights
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Use Rights
Other Intangible Assets
Indefinite-Lived Intangible Assets [Axis]
Indefinite-Lived Intangible Assets, Major Class Name [Domain]
Trademarks
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Finite-Lived Intangible Assets, Net [Abstract]
Finite-Lived Intangible Asset, Useful Life
Finite-Lived Intangible Assets, Gross
Finite-Lived Intangible Assets, Gross
Finite-Lived Intangible Assets, Accumulated Amortization
Accumulated Amortization
Finite-Lived Intangible Assets, Net
Finite-Lived Intangible Assets, Net
Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]
Indefinite-Lived Intangible Assets (Excluding Goodwill)
Indefinite-lived intangible assets
Goodwill
Ending balance
Beginning balance
Goodwill recognized
Gross amount of indefinite-lived intangible assets and goodwill.
Indefinite Lived Intangible Assets Including Goodwill Gross
Subtotal, Original Cost
Carrying amount of indefinite-lived intangible assets and goodwill.
Indefinite Lived Intangible Assets Including Goodwill Net
Subtotal, Net Book Value
Amount before accumulated amortization of intangible assets, including goodwill.
Balance, Original Cost
Balance, Original Cost
Payments to Acquire Productive Assets
Cash payment
Payment to acquire assets
Goodwill, Translation and Measurement Period Adjustments
Currency translation
Inventory, Current [Table]
Inventory [Line Items]
Inventory, Raw Materials and Supplies, Gross
Raw materials and supplies
Inventory, Work in Process, Gross
Work in process
Inventory, Finished Goods, Gross
Finished goods
Inventory Write-down
Inventory adjustment to reflect net realizable value
Property, Plant and Equipment [Table]
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Domain]
Buildings
Leasehold Improvements
Land
Machinery and Equipment
Total of 1) equipment such as desks, chairs) commonly used in offices and stores that have no permanent connection to the structure of a building or utilities and 2) vehicles.
Furniture, Fixtures, and Automobiles
Construction in Progress
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross
Total property, plant, and equipment
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less accumulated depreciation and amortization
Accrued customer fees and rebates
Accrued customer fees and rebates
Employee-related Liabilities, Current
Accrued payroll and related benefits
Carrying value as of the balance sheet date of obligations incurred through that date for estimated refunds due to goods returned by customers (other than under warranty provisions). For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Product Return Accrual, Current
Accrued product returns, current portion
Estimated Litigation Liability
Accrued litigation settlement
Other Accrued Liabilities, Current
Other accrued liabilities
Accrued Liabilities, Current
Total accrued liabilities
Accounts Payable, Current
Accounts payable
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Represents 2.0% convertible senior notes due 2029.
Two Percent Convertible Senior Notes Due Two Thousand Twenty Nine Member
2029 Convertible Notes
Term loan with Wells Fargo Bank due June 2028
Term Loan - Due June 2028
Represents the French Government loan due December 2026.
French Government Loan 4 - Due December 2026
Lender Name [Axis]
Line of Credit Facility, Lender [Domain]
Represents the Seine-Normandie water agency.
Seine-Normandie Water Agency
Represents Loans with Wells Fargo Bank
Wells Fargo Bank
Represents loans with ICBC bank.
ICBC Bank
Credit Facility [Axis]
Credit Facility [Domain]
Line of Credit
Debt Instrument [Line Items]
Debt
Long-Term Debt
Unamortized Debt Issuance Expense
Unamortized debt issuance costs
Finance Lease, Liability, Noncurrent
Equipment under Finance Leases
Total
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]
Contractual Obligation
Total debt
Line of Credit Facility with ICBC Bank due November 2033
Line of Credit Due November 2033
Derivative Instrument [Axis]
Derivative Contract [Domain]
Interest Rate Swap
Debt Instrument, Interest Rate, Stated Percentage
Debt interest rate
Interest Expense, Debt
Amount of the cost of borrowed funds accounted for as the coupon interest expense for debt.
Coupon Interest Expense
Coupon interest expense
Debt Instrument, Face Amount
Principal amount
Aggregate principal amount
Repayments of Senior Debt
Repayment of debt
Debt Issuance Costs, Net
Debt issuance costs
Debt Instrument, Convertible, Conversion Ratio
Debt conversion ratio
Represents the denomination of the principal amount of debt that is used in conversion calculations.
Debt Instrument Principal Amount Denomination For Conversion Into Common Stock
Debt principle amount converted into common stock
Debt Instrument, Convertible, Conversion Price
Debt conversion price per share
Percentage of premium over the last reported sale price in a convertible debt instrument.
Debt Instrument, Convertible, Premium Percentage over Last Reported Sale Price percent
Convertible debt, percentage of premium over the last reported sale price
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger
Convertible debt threshold percentage
Debt Instrument, Convertible, Threshold Trading Days
Convertible debt, threshold trading days
Debt Instrument, Convertible, Threshold Consecutive Trading Days
Convertible debt, threshold consecutive trading days
Threshold number of business days after consecutive trading days that trading price is less than the product of threshold sale price of the common stock and the conversion rate on each trading day to trigger conversion feature.
Debt Instrument, Convertible, Threshold Business Days After Consecutive Trading Period
Threshold business days after consecutive trading period
Threshold period of specified consecutive trading days within which trading price is less than the product of threshold sale price of the common stock and the conversion rate on each trading day to trigger conversion feature.
Debt Instrument, Convertible, Threshold Consecutive Trading Period
Threshold consecutive trading period
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed
Percentage of principal amount redeemed
Represents the trading price as a maximum percentage of product of sale price of common stock and conversion rate on each trading day to determine eligibility of conversion.
Debt Instrument, Convertible, Threshold Trading Price As a Percentage of Product of Sale Price of Common Stock and Conversion Rate
Percentage of product sale price
Debt Instrument, Fair Value Disclosure
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
Debt Instrument Basis Spread Discount On Variable Rate
Prime rate discount percentage
Line of Credit Facility, Maximum Borrowing Capacity
Maximum borrowing capacity
Line of Credit Facility, Fair Value of Amount Outstanding
Borrowings
The amount of net gains (losses) from changes in fair value of interest rate cash flow hedges.
Gain Loss From Change In Fair Value Of Interest Rate Cash Flow Hedges
Gains (losses) from changes in fair values of interest rate swaps
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
Income (loss) before income taxes:
Effective Income Tax Rate Reconciliation, Percent
Income tax provision as a percentage of income before income taxes
Class of Treasury Stock [Table]
Share Repurchase Program [Axis]
Share Repurchase Program [Domain]
November 2014 share repurchase plan.
November 2014 Share Repurchase Plan
Equity, Class of Treasury Stock [Line Items]
Share Repurchase Program, Authorized, Amount
Stock buyback program, authorized amount
Share Repurchase Program, Remaining Authorized, Amount
Increase authorized for share buyback program
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Plan Name [Axis]
Plan Name [Domain]
Information related to the 2015 Equity Incentive Plan.
The 2015 Equity Incentive Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Information related to the 2014 Employee Stock Purchase Plan.
2014 Employee Stock Purchase Plan
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
Average volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Average risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Weighted-average expected life in years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Dividend yield rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Outstanding Options, End of period
Outstanding Options, Beginning of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Options granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Options forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Options expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Exercisable at the end of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Vested and expected to vest, at the end of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding Exercise Price (in dollars per share)
Outstanding Exercise Price (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Options granted (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Exercisable at the end of period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Vested and expected to vest at end of period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Additional Disclosures
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Contractual term
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Outstanding Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Exercisable remaining contractual term (in Years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Exercisable aggregate intrinsic value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Vested and expected to vest aggregate intrinsic value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Vested and expected to vest weighted average remaining contractual term
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Options granted (in dollars per share)
Weighted-average grant date fair value (in Dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Intrinsic value of options exercised
Proceeds from Stock Options Exercised
Cash received from options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Total fair value of the options vested during the period
An arrangement whereby an employee, consultant or member of the Board of Directors is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.
Employee Stock Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Nonvested at end of period
Nonvested at beginning of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares
Options vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Options forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Nonvested at end of period (in dollars per share)
Nonvested at beginning of period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Options vested (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
Options forfeited (in dollars per share)
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Restricted Stock Units (RSUs)
Represents the number of common shares the grantee is to receive at a specified future date for each Restricted Stock Unit ("RSU") awarded.
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Number of Shares of Common Stock Per Award (in Shares)
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Represents Restricted Stock Units (RSUs) issued as compensation.
Restricted Stock Units Issued as Compensation
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Total RSUs outstanding at the end of the period
Total RSUs outstanding at the beginning of the period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
RSUs granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
RSUs forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
RSUs vested
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Stock surrendered to fulfill tax withholding obligations
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Total Fair Market Value of RSUs Issued
Fair value of share-based awards granted during the period.
RSUs granted (in Dollars)
Statement of Income Location, Balance [Axis]
Statement of Income Location, Balance [Domain]
Cost of Revenues
Selling, Distribution, and Marketing
General and Administrative
Research and Development
Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
Defined Contribution Plan, Cost
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate
Defined Benefit Plan, Benefit Obligation
Pension Cost (Reversal of Cost)
Pension Cost
Deferred Compensation Plan Assets
Deferred compensation plan assets
Deferred Compensation Liability, Current and Noncurrent
Deferred compensation plan liabilities
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Line Items]
Area of Real Estate Property
Area of real estate
Lessee, Operating Lease, Term of Contract
Lease term
The amount of monthly lease payment
Monthly Lease Payments
Monthly lease payments
Annual percentage increase of the lease payment
Annual lease payment increase, percentage
Number of annual periods
Number of Annual Periods
Number of annual periods
Operating Lease, Liability
Lease liability
Total
Incremental increase in the operating lease borrowing rate.
Operating Lease Incremental Borrowing Rate
Incremental borrowing rate
Lessee, Operating Lease, Renewal Term
Lease renewal term
Operating Lease, Cost
Operating lease costs
Short-Term Lease, Cost
Short-term lease costs
Finance Lease, Right-of-Use Asset, Amortization
Amortization of right-of-use assets
Finance Lease, Interest Expense
Interest on lease liabilities
Amount of finance lease cost.
Finance Lease Cost
Total financed lease cost
Lease, Cost
Total lease costs
Operating Lease, Payments
Operating cash flows paid for operating Leases
Finance Lease, Interest Payment on Liability
Operating cash flows paid for finance leases
Finance Lease, Principal Payments
Financing cash flows paid for finance leases
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Right-of use assets obtained in exchange for lease obligations: Operating leases
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease term (years), Operating leases
Finance Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease term (years), Finance leases
Operating Lease, Weighted Average Discount Rate, Percent
Weighted-average discount rate, Operating leases
Finance Lease, Weighted Average Discount Rate, Percent
Weighted-average discount rate, Finance leases
n/a
Lessee Operating Lease Liability Payments [Abstract]
Operating Leases
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
2026 (excluding the three months ended March 31, 2026)
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Lessee, Operating Lease, Liability, to be Paid, Year Four
2030
Lessee, Operating Lease, Liability, to be Paid, after Year Five
Thereafter
Lessee, Operating Lease, Liability, to be Paid
Total lease payments
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: interest
n/a
Lessee Finance Lease Liability Payments [Abstract]
Finance Leases
Finance Lease, Liability, to be Paid, Remainder of Fiscal Year
2026 (excluding the three months ended March 31, 2026)
Finance Lease, Liability, to be Paid, Year One
2027
Finance Lease, Liability, to be Paid
Total lease payments
Finance Lease, Liability, Undiscounted Excess Amount
Less: interest
n/a
Lessee Lease Liability Payments [Abstract]
Total
Amount of lessee's undiscounted obligation for lease payment having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.
Lease Liability Payments Remainder Of Fiscal Year
2026 (excluding the three months ended March 31, 2026)
Amount of lessee's undiscounted obligation for lease payments for lease to be paid in next fiscal year following current fiscal year.
Lease Liability Payments Due Next Twelve Months
2027
Amount of lessee's undiscounted obligation for lease payments for lease, due in second fiscal year following latest fiscal year.
Lease Liability Payments Due Year Two
2028
Amount of lessee's undiscounted obligation for lease payments for lease, due in third fiscal year following latest fiscal year.
Lease Liability Payments Due Year Three
2029
Amount of lessee's undiscounted obligation for lease payments for lease, due in fourth fiscal year following latest fiscal year.
Lease Liability Payments Due Year Four
2030
Amount of lessee's undiscounted obligation for lease payments for lease, due after fifth fiscal year following latest fiscal year.
Lease Liability Payments Due After Year Five
Thereafter
Amount of lessee's undiscounted obligation for lease payments for lease.
Lease Liability Payments Due
Total lease payments
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for lease.
Lease Liability Undiscounted Excess Amount
Less: interest
Present value of lessee's discounted obligation for lease payments from lease.
Lease Liability
Total
Asset Acquisition [Table]
Scenario [Axis]
Scenario [Domain]
Represents the sales milestone achievement scenario one relating to contingent consideration under asset acquisition.
Asset Acquisition, Contingent Consideration, Sales Milestone Achievement One [Member]
Represents the sales milestone achievement scenario two relating to contingent consideration under asset acquisition.
Asset Acquisition, Contingent Consideration, Sales Milestone Achievement Two [Member]
Represents the sales milestone achievement scenario three relating to contingent consideration under asset acquisition.
Asset Acquisition, Contingent Consideration, Sales Milestone Achievement Three [Member]
Represents the sales milestone achievement scenario one relating to earnout liability under asset acquisition.
Asset Acquisition, Earnout Liability, Sales Milestone Achievement One [Member]
Represents the sales milestone achievement scenario two relating to
earnout liability under asset acquisition.
Asset Acquisition, Earnout Liability, Sales Milestone Achievement Two [Member]
Represents the sales milestone achievement scenario three relating to
earnout liability under asset acquisition.
Asset Acquisition, Earnout Liability, Sales Milestone Achievement Three [Member]
Asset Acquisition [Line Items]
Asset Acquisition, Consideration Transferred, Contingent Consideration
Contingent consideration
Threshold annual sales milestone achievement for receiving contingent consideration under asset acquisition.
Asset Acquisition, Contingent Consideration, Threshold Annual Sales Milestone
Threshold of annual sales milestone
Period after closing considered for achievement of sales milestone for payment of contingent consideration.
Asset Acquisition, Contingent Consideration, Period After Closing Considered For Achievement Of Sales Milestone
Period after closing considered for achievement of sales milestone
Maximum number of times the contingent consideration is payable on achievement of sales milestone.
Asset Acquisition, Contingent Consideration Payable On Achievement Of Sales Milestone, Threshold Number
Number of potential contingent consideration payments
Threshold cumulative sales milestone achievement for receiving contingent consideration under asset acquisition.
Asset Acquisition, Contingent Consideration, Threshold Cumulative Sales Milestone
Threshold cumulative sales milestone
Threshold earnout liability assumed under asset acquisition.
Asset Acquisition, Threshold Earnout Liability Assumed
Earnout obligations
Threshold annual net sales milestone achievement for payment of earnout liability under asset acquisition.
Asset Acquisition, Earnout Liability, Threshold Annual Sales Milestone
Threshold annual net sales milestone achievement for payment of earnout liability
Asset Acquisition, Consideration Transferred, Transaction Cost
Asset Acquisition Transaction Cost
Transaction costs
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement [Member]
Represents licensing agreement.
Licensing Agreement
Represents development milestone payments.
Development Milestone Payments
Represents sales milestone payments.
Sales Milestone Payments
Royalty Payments
Counterparty Name [Axis]
Counterparty Name [Domain]
Nanjing Anji Biotechnology Co., Ltd.
Nanjing Anji Biotechnology Co., Ltd.
Related and Nonrelated Parties [Axis]
Related and Nonrelated Parties [Domain]
Represents Nanjing Hanxin Pharmaceutical Technology Co., Ltd., or Hanxin.
Hanxin
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Represents number of licensed products.
Number Of Licensed Products
Number of licensed products
Threshold cumulative Development milestone achievement for receiving contingent consideration under asset acquisition.
Asset Acquisition, Contingent Consideration, Threshold Cumulative Development Milestone
Threshold Cumulative Development Milestones
Maximum Royalty Amount Owed, Contingent On Sales of Products
Maximum Royalty Amount Owed, Contingent On Sales of Products
Maximum royalty amount owed, contingent on sales of products
Royalty Payment Percentage
Royalty Payment Percentage
Related Party Transaction [Table]
Nanjing Letop Biotechnology Technology Co. Ltd. [Member]
Letop
Hong Kong Genreach Limited, subsidiary of Hanxin [Member]
Genreach
Represents Nanjing Chengong Pharmaceutical Co., Limited.
Chengong
Related Party Transaction [Line Items]
Increase (Decrease) in Due to Related Parties
Increase in agreement cost
Related Party Transaction, Purchases from Related Party
Payment to related party
Other Liabilities, Current
Other Receivables
Receivables from Related Party
Percentage of ownership in investment after spin-off transaction.
Ownership Percentage After Spinoff Transaction
Ownership after transaction
Loss Contingencies [Table]
Litigation Status [Axis]
Litigation Status [Domain]
Pending Litigation
Litigation Case [Axis]
Litigation Case [Domain]
Employee litigation with International medication Systems, Limited.
Employee Litigation v. International Medication Systems, Limited
Loss Contingencies [Line Items]
Represents William J. Peters.
William J. Peters